The FDA has gone through a lot of painstaking work to ensure that they protect against hindering the cutting edge of industry to allow life saving medications to come to market. But If you've got 20 years on a patent and let's say 12 years after your biologic is approved, you should be allowed to recoup that money in that period of time. But once that patent's over, insurgents should be allowed to enter the marketplace to appropriately compete. That's what the ecosystem of fairness should represent. (19:33–19:42)
CLAIM
Asserts that companies should recoup investments within 20 years of a patent and 12 years post-biologic approval.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
